amphotericin-b and Behcet-Syndrome

amphotericin-b has been researched along with Behcet-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for amphotericin-b and Behcet-Syndrome

Article	Year
Disseminated cryptococcosis with cutaneous lesions complicating steroid therapy for Behçet's disease. International journal of dermatology, 2003, Volume: 42, Issue:10 Topics: Adult; Amphotericin B; Antifungal Agents; Behcet Syndrome; Cryptococcosis; Cryptococcus neoformans; Glucocorticoids; Humans; Leg Ulcer; Male; Prednisone	2003
Transfer factor II: results of therapy. Birth defects original article series, 1975, Volume: 11, Issue:1 Transfer factor is a dialyzable extract of sensitized leukocytes, which transfers reactivity from skin test-positive donors to skin test-negative recipients. Transfer factor supplied by our laboratory has been used therapeutically to induce cellular immunity in 78 patients around the world. Many patients received multiple doses of transfer factor ranging from 1 unit given every 6 months for 3 years to 1 unit every week for 6 months to as much as 8 units per week for a brief period. A total of 299 units of transfer factor have been given. Diseases in which transfer factor appeared to cause improvement include the Wiskott-Aldrich syndrome, severe combined immunodeficiency disease, mucocutaneous candidiasis, chronic active hepatitis, coccidioidmycosis, dysgammaglobulinemia, Behcet disease, aphthous stomatitis, linear morphea, familial keratoacanthoma and malignancy. Topics: Amphotericin B; Behcet Syndrome; Binding Sites, Antibody; Candidiasis, Cutaneous; Coccidioidomycosis; Dysgammaglobulinemia; Hepatitis; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Immunotherapy; Keratoacanthoma; Macrophage Migration-Inhibitory Factors; Monocytes; Neoplasms; Scleroderma, Localized; Stomatitis, Aphthous; Transfer Factor; Wiskott-Aldrich Syndrome	1975

Article

Year

Disseminated cryptococcosis with cutaneous lesions complicating steroid therapy for Behçet's disease.

International journal of dermatology, 2003, Volume: 42, Issue:10

Topics: Adult; Amphotericin B; Antifungal Agents; Behcet Syndrome; Cryptococcosis; Cryptococcus neoformans; Glucocorticoids; Humans; Leg Ulcer; Male; Prednisone

2003

Transfer factor II: results of therapy.

Birth defects original article series, 1975, Volume: 11, Issue:1

Transfer factor is a dialyzable extract of sensitized leukocytes, which transfers reactivity from skin test-positive donors to skin test-negative recipients. Transfer factor supplied by our laboratory has been used therapeutically to induce cellular immunity in 78 patients around the world. Many patients received multiple doses of transfer factor ranging from 1 unit given every 6 months for 3 years to 1 unit every week for 6 months to as much as 8 units per week for a brief period. A total of 299 units of transfer factor have been given. Diseases in which transfer factor appeared to cause improvement include the Wiskott-Aldrich syndrome, severe combined immunodeficiency disease, mucocutaneous candidiasis, chronic active hepatitis, coccidioidmycosis, dysgammaglobulinemia, Behcet disease, aphthous stomatitis, linear morphea, familial keratoacanthoma and malignancy.

Topics: Amphotericin B; Behcet Syndrome; Binding Sites, Antibody; Candidiasis, Cutaneous; Coccidioidomycosis; Dysgammaglobulinemia; Hepatitis; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Immunotherapy; Keratoacanthoma; Macrophage Migration-Inhibitory Factors; Monocytes; Neoplasms; Scleroderma, Localized; Stomatitis, Aphthous; Transfer Factor; Wiskott-Aldrich Syndrome

1975